Bainan Biotech ApS: Financial statements 2022
CVR: 39904276
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Bainan Biotech ApS (CVR 39904276) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,230,180 and a net result of DKK -3,128,882 compared with DKK -9,063,823 the year before. Equity in the 2022 report amounted to DKK -12,543,766. The company had 4 employees in the financial year.
- Gross Profit
- DKK -1,230,180
- Profit/Loss
- DKK -3,128,882
- Equity
- DKK -12,543,766
- Total Assets
- DKK 3,707,872
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.2 mio. | -3.1 mio. | -12.5 mio. | 4 |
| 2021 | - | -3.7 mio. | -9.1 mio. | -9.4 mio. | 9 |
| 2020 | - | 2 mio. | -510 t. | -351 t. | 1 |
Official annual report
Keep an eye on Bainan Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Bainan Biotech ApS has published its annual report for 2021. Gross profit came to DKK -3,709,804, and the net result was DKK -9,063,823.
About Bainan Biotech ApS
Bainan Biotech ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company has been dissolved on 20 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity in the 2023 report amounted to DKK -15,215,743.